Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Pareek

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Clinical Hypertension|December 7, 2019
Compelling therapy of LVH: straight (and not-so-straight) inferences from evidenceRavi Tejraj Mehta, Anil Pareek, Shruti Dharmadhikari
The Indian Journal of Medical Research|August 20, 2020
Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimenAnil Pareek, Sudhir Bhandari, Ravi Tejraj Mehta
Rheumatology Advances in Practice|November 11, 2020
Hydroxychloroquine and QT prolongation: reassuring data in approved indicationsAnil Pareek, Tarun S Sharma, Ravi Tejraj Mehta
Open Heart|February 11, 2025
Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrelAnil Pareek, Nitin Chandurkar, Vivek Raut, et al.
American Journal of Therapeutics|January 23, 2010
Evaluation of efficacy and tolerability of gliclazide and metformin combination: a multicentric study in patients with type 2 diabetes mellitus uncontrolled on monotherapy with sulfonylurea or metforminAnil Pareek, Nitin Chandurkar, Shyamsundar Zawar, et al.
Indian Journal of Endocrinology and Metabolism|June 19, 2018
REVEAL Study: Reveals the Limitations of Cholesteryl Ester Transfer Protein InhibitionAnil Pareek, Indranil Purkait, Anu Grover, et al.
Pharmacognosy Reviews|November 19, 2011
Feverfew (Tanacetum parthenium L.): A systematic reviewAnil Pareek, Manish Suthar, Garvendra S Rathore, et al.
Indian Heart Journal|November 15, 2020
DAPA-HF study: Are the benefits uniform across non-diabetic subgroupsAnil Pareek, Rajesh Rajput, Hriday Kumar Chopra, et al.
Rheumatology Advances in Practice|November 6, 2019
Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquineAnil Pareek, Ravi Tejraj Mehta, Shruti Dharmadhikari, et al.
Pharmacognosy Reviews|January 27, 2012
Aerva lanata: A review on phytochemistry and pharmacological aspectsManoj Goyal, Anil Pareek, B P Nagori, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Clinical Hypertension|December 7, 2019
Compelling therapy of LVH: straight (and not-so-straight) inferences from evidenceRavi Tejraj Mehta, Anil Pareek, Shruti Dharmadhikari
The Indian Journal of Medical Research|August 20, 2020
Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimenAnil Pareek, Sudhir Bhandari, Ravi Tejraj Mehta
Rheumatology Advances in Practice|November 11, 2020
Hydroxychloroquine and QT prolongation: reassuring data in approved indicationsAnil Pareek, Tarun S Sharma, Ravi Tejraj Mehta
Open Heart|February 11, 2025
Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrelAnil Pareek, Nitin Chandurkar, Vivek Raut, et al.
American Journal of Therapeutics|January 23, 2010
Evaluation of efficacy and tolerability of gliclazide and metformin combination: a multicentric study in patients with type 2 diabetes mellitus uncontrolled on monotherapy with sulfonylurea or metforminAnil Pareek, Nitin Chandurkar, Shyamsundar Zawar, et al.
Indian Journal of Endocrinology and Metabolism|June 19, 2018
REVEAL Study: Reveals the Limitations of Cholesteryl Ester Transfer Protein InhibitionAnil Pareek, Indranil Purkait, Anu Grover, et al.
Pharmacognosy Reviews|November 19, 2011
Feverfew (Tanacetum parthenium L.): A systematic reviewAnil Pareek, Manish Suthar, Garvendra S Rathore, et al.
Indian Heart Journal|November 15, 2020
DAPA-HF study: Are the benefits uniform across non-diabetic subgroupsAnil Pareek, Rajesh Rajput, Hriday Kumar Chopra, et al.
Rheumatology Advances in Practice|November 6, 2019
Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquineAnil Pareek, Ravi Tejraj Mehta, Shruti Dharmadhikari, et al.
Pharmacognosy Reviews|January 27, 2012
Aerva lanata: A review on phytochemistry and pharmacological aspectsManoj Goyal, Anil Pareek, B P Nagori, et al.
Pageof 7